Related Experiment Video
Updated: May 7, 2026

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway
Jennifer A Faralli1, Debjani Gagen1, Mark S Filla2
1Department of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI 53706, USA.
Dexamethasone (DEX) treatment increases αvβ3 integrin expression by upregulating the β3 subunit. This effect is a secondary glucocorticoid response mediated by the calcineurin/NFAT pathway and persists after DEX removal.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Integrins are crucial cell surface receptors involved in cell adhesion and signaling.
- Glucocorticoids, like dexamethasone (DEX), are potent anti-inflammatory agents with diverse cellular effects.
- The αvβ3 integrin plays a role in various physiological and pathological processes, including inflammation and angiogenesis.
Purpose of the Study:
- To investigate the regulatory mechanisms by which dexamethasone (DEX) influences the expression and activity of the αvβ3 integrin.
- To elucidate the specific integrin subunits affected by DEX treatment.
- To identify the signaling pathways involved in DEX-mediated αvβ3 integrin regulation.
Main Methods:
- Flow cytometry (FACS) was used to analyze αvβ3 integrin expression and activation.
- Quantitative real-time PCR (qPCR) was employed to measure β3 and β1 integrin mRNA levels.
- Inhibition studies using RU486, cycloheximide, cyclosporin A (CsA), and FK506 were conducted to probe the underlying molecular mechanisms.
Main Results:
- DEX treatment induced a significant upregulation of αvβ3 integrin, characterized by increased expression of the β3 integrin subunit.
- β3 integrin mRNA levels were elevated by DEX in a time-dependent manner and remained high even after DEX withdrawal.
- DEX-induced β3 integrin mRNA upregulation was partly due to increased mRNA half-life and required de novo protein synthesis of an activation factor, involving the calcineurin/NFAT pathway.
Conclusions:
- Dexamethasone treatment leads to a sustained increase in αvβ3 integrin expression, primarily through the upregulation of the β3 integrin subunit.
- This DEX-induced effect is a secondary glucocorticoid response mediated by the calcineurin/NFAT signaling pathway.
- The findings suggest a novel mechanism by which glucocorticoids modulate integrin function, potentially impacting inflammatory and immune responses.
More Related Videos
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
TGF - β Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...

